ERBB2 and urinary bladder carcinoma: Besides the amplification/overexpression of HER2, somatic HER2 gene mutations have been detected in a range of human cancer types, including prostate neuroendocrine cancer, metastatic cutaneous squamous cell carcinoma, and bladder cancer [17,18].